Dr Mark Horowitz MBBS PhD is Clinical Research Fellow in Psychiatry at North East London NHS Foundation Trust (NELFT), Visiting Lecturer in Psychopharmacology at King’s College London, an Honorary Clinical Research Fellow at University College London and a trainee psychiatrist. He has a PhD from the Institute of Psychiatry, Psychology and Neuroscience at King’s College London in the neurobiology of depression and antidepressant action. He is the lead author of the Maudsley Deprescribing Guidelines and is an associate editor of the journal Therapeutic Advances in Psychopharmacology.
He co-authored the recent Royal College of Psychiatrists’ guidance on ‘Stopping Antidepressants’, and his work informed the recent NICE guidelines on safe tapering of psychiatric medications, including antidepressants, benzodiazepines and z-drugs. He has worked with the NHS to develop national guidance for safe deprescribing for clinicians and has been commissioned by Health Education England to prepare a teaching module on how to safely stop antidepressants.
He has written several papers about safe approaches to tapering psychiatric medications including publications in The Lancet Psychiatry, JAMA Psychiatry and Schizophrenia Bulletin. He has an interest in rational psychopharmacology and deprescribing psychiatric medication. He has experienced the difficulty of coming off psychiatric medications first hand which has informed much of his work.